Invivyd Q1 FY26 net loss widens to $41.4 million; revenue rises to $13.74 million

Invivyd

Invivyd

IVVD

0.00
  • Invivyd posted a net loss of USD 41.4 million for three months ended March 31, 2026, widening from USD 16.29 million a year earlier.
  • Revenue rose 21.58% to USD 13.74 million, while research and development expense nearly tripled to USD 30.73 million.
  • Selling, general and administrative costs climbed 49.95% to USD 25.12 million, pushing operating loss to USD 43.14 million.
  • Cash and cash equivalents totaled USD 184.2 million as of March 31, 2026; Invivyd also reported an April at-the-market sale of 11,803,589 shares for USD 19.4 million in net proceeds.
  • VYD2311 Phase 3 DECLARATION trial was upsized by about 500 subjects, with top-line data expected in third quarter of 2026; management said substantial doubt exists about ability to continue as a going concern beyond one year without additional financing.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Invivyd Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001193125-26-222779), on May 14, 2026, and is solely responsible for the information contained therein.

This page is machine-translated. Sahm tries to improve but does not guarantee the accuracy and reliability of the translation, and will not be liable for any loss or damage caused by any inaccuracy or omission of the translation. *Disclaimer: The above content only represents the author's personal position and opinion and does not represent any position of Sahm Capital Financial Company and Sahm cannot confirm the authenticity, accuracy, and originality of the above content. Investors should consider the risks of investment products in light of their circumstances before making any investment decisions. When necessary, please consult a professional investment advisor. Sahm does not provide any investment advice, nor does it make any commitments and guarantees.